                         SEQUENCE LISTING

<110>  DSM IP Assets B.V.
 
<120>  Novel composition

<130>  27260

<160>  12    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  palmitoyl

<400>  1

Arg Phe His Xaa 
1               


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  palmitoyl

<400>  2

Xaa Lys Val Lys 
1               


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  elaidyl

<400>  3

Xaa Lys Phe Lys 
1               


<210>  4
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  hexanoyl

<400>  4

Xaa Ala Arg Xaa 
1               


<210>  5
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  palmitoyl

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  2,4-diaminobutyroyl

<400>  5

Xaa Lys Val Xaa 
1               


<210>  6
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  palmitoyl

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  2,4-diaminobutyroyl

<400>  6

Xaa Lys Val Xaa Thr 
1               5   


<210>  7
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  palmitoyl

<400>  7

Xaa Lys Thr Thr Lys Ser 
1               5       


<210>  8
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  palmitoyl

<400>  8

Xaa Gly His Lys 
1               


<210>  9
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  palmitoyl

<400>  9

Xaa Gly Lys His 
1               


<210>  10
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  palmitoyl

<400>  10

Xaa Gly Gln Pro Arg 
1               5   


<210>  11
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  palmitoyl

<400>  11

Xaa Val Gly Val Ala Pro Gly 
1               5           


<210>  12
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  palmitoyl

<400>  12

Xaa Ala Glu Asp Glu Pro Leu Leu Met Glu 
1               5                   10  


